These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10318841)

  • 21. Experimental determination of the membrane topology of the Plasmodium protease Plasmepsin V.
    Tarr SJ; Osborne AR
    PLoS One; 2015; 10(4):e0121786. PubMed ID: 25849462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human erythroid spectrin alpha subunit and its SH3 domain are sensitive to acidic Plasmodium falciparum proteolytic activity.
    Le Bonniec SL; Fournier C; Deregnaucourt C; Grellier P; Dhermy D; Lecomte MC; Schrevel J
    C R Acad Sci III; 1996 Nov; 319(11):1011-7. PubMed ID: 9033845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
    Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
    J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.
    Liu P; Robbins AH; Marzahn MR; McClung SH; Yowell CA; Stevens SM; Dame JB; Dunn BM
    PLoS One; 2015; 10(10):e0141758. PubMed ID: 26510189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target.
    Nezami A; Luque I; Kimura T; Kiso Y; Freire E
    Biochemistry; 2002 Feb; 41(7):2273-80. PubMed ID: 11841219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of plasmepsin V in export of diverse protein families from the Plasmodium falciparum exportome.
    Boddey JA; Carvalho TG; Hodder AN; Sargeant TJ; Sleebs BE; Marapana D; Lopaticki S; Nebl T; Cowman AF
    Traffic; 2013 May; 14(5):532-50. PubMed ID: 23387285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.
    Hodder AN; Sleebs BE; Czabotar PE; Gazdik M; Xu Y; O'Neill MT; Lopaticki S; Nebl T; Triglia T; Smith BJ; Lowes K; Boddey JA; Cowman AF
    Nat Struct Mol Biol; 2015 Aug; 22(8):590-6. PubMed ID: 26214367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects on growth, hemoglobin metabolism and paralogous gene expression resulting from disruption of genes encoding the digestive vacuole plasmepsins of Plasmodium falciparum.
    Bonilla JA; Moura PA; Bonilla TD; Yowell CA; Fidock DA; Dame JB
    Int J Parasitol; 2007 Mar; 37(3-4):317-27. PubMed ID: 17207486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum.
    Shenai BR; Sijwali PS; Singh A; Rosenthal PJ
    J Biol Chem; 2000 Sep; 275(37):29000-10. PubMed ID: 10887194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase.
    Francis SE; Gluzman IY; Oksman A; Knickerbocker A; Mueller R; Bryant ML; Sherman DR; Russell DG; Goldberg DE
    EMBO J; 1994 Jan; 13(2):306-17. PubMed ID: 8313875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trafficking of plasmepsin II to the food vacuole of the malaria parasite Plasmodium falciparum.
    Klemba M; Beatty W; Gluzman I; Goldberg DE
    J Cell Biol; 2004 Jan; 164(1):47-56. PubMed ID: 14709539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant plasmepsin 1 from the human malaria parasite plasmodium falciparum: enzymatic characterization, active site inhibitor design, and structural analysis.
    Liu P; Marzahn MR; Robbins AH; Gutiérrez-de-Terán H; Rodríguez D; McClung SH; Stevens SM; Yowell CA; Dame JB; McKenna R; Dunn BM
    Biochemistry; 2009 May; 48(19):4086-99. PubMed ID: 19271776
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation.
    Francis SE; Gluzman IY; Oksman A; Banerjee D; Goldberg DE
    Mol Biochem Parasitol; 1996 Dec; 83(2):189-200. PubMed ID: 9027752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
    Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prodomain processing of recombinant plasmepsin II and IV, the aspartic proteases of Plasmodium falciparum, is auto- and trans-catalytic.
    Kim YM; Lee MH; Piao TG; Lee JW; Kim JH; Lee S; Choi KM; Jiang JH; Kim TU; Park H
    J Biochem; 2006 Feb; 139(2):189-95. PubMed ID: 16452306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation mechanism of plasmepsins, pepsin-like aspartic proteases from Plasmodium, follows a unique trans-activation pathway.
    Rathore I; Mishra V; Patel C; Xiao H; Gustchina A; Wlodawer A; Yada RY; Bhaumik P
    FEBS J; 2021 Jan; 288(2):678-698. PubMed ID: 32385863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apical surface expression of aspartic protease Plasmepsin 4, a potential transmission-blocking target of the plasmodium ookinete.
    Li F; Patra KP; Yowell CA; Dame JB; Chin K; Vinetz JM
    J Biol Chem; 2010 Mar; 285(11):8076-83. PubMed ID: 20056606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cysteine protease activity from Plasmodium falciparum cleaves human erythrocyte ankyrin.
    Raphael P; Takakuwa Y; Manno S; Liu SC; Chishti AH; Hanspal M
    Mol Biochem Parasitol; 2000 Oct; 110(2):259-72. PubMed ID: 11071281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor.
    Nezami A; Kimura T; Hidaka K; Kiso A; Liu J; Kiso Y; Goldberg DE; Freire E
    Biochemistry; 2003 Jul; 42(28):8459-64. PubMed ID: 12859191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High level expression and characterisation of Plasmepsin II, an aspartic proteinase from Plasmodium falciparum.
    Hill J; Tyas L; Phylip LH; Kay J; Dunn BM; Berry C
    FEBS Lett; 1994 Sep; 352(2):155-8. PubMed ID: 7925966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.